NCT03197506 2025-04-06
Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
Mayo Clinic
Phase 2 Active not recruiting
Mayo Clinic
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute